Medication info

Pamoxcl Duo Syrup 228 mg / 5 mL (Amoxicillin-Clavulanate Potassium (7:1))

Prescription medicationSyrupOralApproval withdrawn
Ingredient · strength
Amoxicillin Hydrate›36.326g / 100gDilute Potassium Clavulanate›10.352g / 100g
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
A white or pale yellow powder that is dissolved to prepare syrup for use.
Packaging
50 mL/bottle
Approval status
Approval withdrawn

MFDS item code 200200624 · Notified 2002.02.21

This product's status changed to Approval withdrawn on 2025.02.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
For recurrent tonsillitis and other upper respiratory infections, lower respiratory infections, urinary tract infections, and mild to moderate skin and soft tissue infections, amoxicillin/clavulanate potassium is typically administered at a dosage of 25 mg/3.6 mg per kg of body weight per day divided into two doses. In the case of upper respiratory infections like otitis media and sinusitis, lower respiratory infections such as bronchopneumonia, and severe urinary tract infections, amoxicillin/clavulanate potassium is typically administered at a dosage of 45 mg/6.4 mg per kg of body weight per day.
Child dose
For mild to moderate infections, such as upper respiratory tract infections including recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg/kg of body weight per day of amoxicillin/potassium clavulanate, divided into 2 doses. For severe infections, such as upper respiratory tract infections including otitis media and sinusitis, lower respiratory tract infections including bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg/kg of body weight per day of amoxicillin/potassium clavulanate, divided into 2 doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal failure.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is used to treat infections caused by various bacteria. It is effective for respiratory infections such as acute and chronic bronchitis and pneumonia, as well as tonsillitis, sinusitis, and otitis media. It is also used to treat urinary tract infections like cystitis, urethritis, and pyelonephritis, as well as pelvic infections and gonorrhea. It treats skin and soft tissue infections, such as furuncle, abscess, cellulitis, and wound infections, and is also used for osteomyelitis and dental infections. This medication helps improve recovery for patients suffering from diverse bacterial infections.

How to take

Adult dose

For recurrent tonsillitis and other upper respiratory infections, lower respiratory infections, urinary tract infections, and mild to moderate skin and soft tissue infections, amoxicillin/clavulanate potassium is typically administered at a dosage of 25 mg/3.6 mg per kg of body weight per day divided into two doses. In the case of upper respiratory infections like otitis media and sinusitis, lower respiratory infections such as bronchopneumonia, and severe urinary tract infections, amoxicillin/clavulanate potassium is typically administered at a dosage of 45 mg/6.4 mg per kg of body weight per day.

Child dose

For mild to moderate infections, such as upper respiratory tract infections including recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg/kg of body weight per day of amoxicillin/potassium clavulanate, divided into 2 doses. For severe infections, such as upper respiratory tract infections including otitis media and sinusitis, lower respiratory tract infections including bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg/kg of body weight per day of amoxicillin/potassium clavulanate, divided into 2 doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal failure.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to certain patients. For example, patients with allergic reactions to this medication's components or to penicillin-class drugs, patients with infectious mononucleosis or lymphocytic leukemia, patients with liver dysfunction, and those with genetic issues such as lactose intolerance should not use this medication. Furthermore, patients with impaired liver or kidney function, patients with allergic tendencies, those who have difficulty taking medications orally, and patients with gastrointestinal diseases should use this medication with caution. Gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain may occur, and rarely, liver dysfunction or skin rashes, allergic reactions, blood abnormalities, kidney problems, central nervous system disorders, etc. may arise. Especially, severe allergic reactions or anaphylactic shock may occur, so the patient's condition should be closely monitored after administration. Long-term use should consider the risk of resistant bacteria and overgrowth of non-sensitive bacteria, recommending treatment for the minimum duration necessary, with regular checks of liver and kidney function. This medication may interact with other drugs, so patients currently taking any medications should inform their doctor or pharmacist. The use of this medication during pregnancy or breastfeeding should be carefully considered, especially avoiding use during the first three months of pregnancy is recommended. The safety of this medication has not been established in children, especially in newborns under 2 months or premature infants. Elderly patients may experience adverse reactions more easily due to reduced bodily function and should use this medication with caution, adjusting dosing and intervals accordingly. Lastly, this medication should be stored in a closed container to protect from air and moisture, kept in a cool and dry place below 25 degrees Celsius, maintaining its effectiveness.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis accompanied by hematochezia, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized pustular psoriasis, drug reactions accompanied by eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased secretion, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, antispasmodic, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, tooth discoloration, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, stomachache, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect from air and moisture, ideally in a cool and dry place below 25 degrees Celsius. Such storage will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

A white or pale yellow powder that is dissolved to prepare syrup for use.

Package unit

50 mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.